Review



cd3 microbead miltenyi biotec cat  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec cd3 microbead miltenyi biotec cat
    Cd3 Microbead Miltenyi Biotec Cat, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human+-+lyophilized/pm42167232-239-252-254
    Average 96 stars, based on 110 article reviews
    cd3 microbead miltenyi biotec cat - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation
    Article Snippet: These cells were isolated by the supplier from the peripheral blood of healthy donors using Ficoll-Paque (Cytiva, #17144002) according to the manufacturer's instructions, in compliance with relevant ethical standards and guidelines. .. Human T cells were isolated through immunomagnetic sorting (Miltenyi, #130-097-043) using CD3 antibody-conjugated magnetic beads. .. CD8 + T cells were purified from PBMCs by negative selection using a commercial CD8 + T Cell Isolation Kit (Miltenyi, #130-096-495).

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Magnetic Beads:

    Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation
    Article Snippet: These cells were isolated by the supplier from the peripheral blood of healthy donors using Ficoll-Paque (Cytiva, #17144002) according to the manufacturer's instructions, in compliance with relevant ethical standards and guidelines. .. Human T cells were isolated through immunomagnetic sorting (Miltenyi, #130-097-043) using CD3 antibody-conjugated magnetic beads. .. CD8 + T cells were purified from PBMCs by negative selection using a commercial CD8 + T Cell Isolation Kit (Miltenyi, #130-096-495).

    Recombinant:

    Article Title: Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies TotalSeqTM-C0251 anti-human Hashtag 1 Antibody Biolegend Cat: 394661; RRID: AB_2801031 TotalSeqTM-C0252 anti-human Hashtag 2 Antibody Biolegend Cat: 394663; RRID: AB_2801032 TotalSeqTM-C0253 anti-human Hashtag 3 Antibody Biolegend Cat: 394665; RRID: AB_2801033 CD40 Antibody, anti-human Miltenyi Biotec Cat: 130-094-133; RRID: AB_2811582 BD HorizonTM BUV496 Mouse Anti-Human CD3 BD Biosciences Cat: 612940; RRID: AB_2870222 APC/Cyanine7 anti-human CD4 Antibody Biolegend Cat: 317418; RRID: AB_571947 FITC anti-human CD8a Antibody Biolegend Cat: 300906; RRID: AB_314110 Brilliant Violet 650TM anti-human CD14 Antibody Biolegend Cat: 301836; RRID: AB_2563799 Brilliant Violet 510TM anti-human CD19 Antibody Biolegend Cat: 302242; RRID: AB_2561668 Alexa Fluor® 700 anti-human CD56 (NCAM) Recombinant Antibody Biolegend Cat: 392418; RRID: AB_2728414 Brilliant Violet 605TM anti-human CD69 Antibody Biolegend Cat: 310938; RRID: AB_2562307 Alexa Fluor® 647 anti-human CD134 (OX40) Antibody Biolegend Cat: 350018; RRID: AB_2571938 PE/Cyanine5 anti-human CD137 (4-1BB) Antibody Biolegend Cat: 309808; RRID: AB_830670 PE/DazzleTM 594 anti-human CD154 (CD40L) Antibody Biolegend Cat: 310840; RRID: AB_2566245 APC anti-human CD80 Antibody Biolegend Cat: 375403; RRID: AB_2890817 PE anti-human HLA-DM Antibody Biolegend Cat: 358003; RRID: AB_2562027 Bacterial and virus strains BCG AJ Vaccines N/A Biological samples Fetal calf serum Labtech Cat: FCS-SA/500 Chemicals, peptides, and recombinant proteins RPMI 1640 Sigma Cat: R0883 L-glutamine Gibco Cat: G7513 Penicillin-streptomycin Gibco Cat: P0781 DMEM Sigma Cat: D6546 RPMI 1640 medium with 10 mM HEPES Gibco Cat: 22400089 GM-CSF PeproTech Cat: 300-03 IL-4 PeproTech Cat: 200-04 PPD-T AJ Vaccines NA RBC lysis solution Qiagen Cat: 158904 Sodium pyruvate Gibco Cat: 11360039 DMSO Sigma Cat: D2650 Lymphoprep Stemcell Technologies Cat: 7811 CD3 microbead Miltenyi Biotec Cat: 130-097-043 (Continued on next page) e1 Cell Reports Medicine 7, 102830, June 16, 2026 Article ll OPEN ACCESS .. REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcal Enterotoxin B Sigma Cat: S4881 Solution 13 Chemometec Cat: 910-3013 Human TruStain FcXTM BioLegend Cat: 422301 Dulbecco’s Phosphate Buffered Saline Sigma Cat: D8537 MACS® BSA Stock Solution Miltenyi Biotec Cat: 130-091-376 RLT Plus buffer Qiagen Cat: 1053393 β-mercaptoethanol Sigma Cat: M3148 RNase-free water Thermo Fisher Cat: AM9937 Benzonase Sigma Cat: E1014 LIVE/DEADTM Fixable Aqua Dead Cell Stain Kit Thermo Fisher Cat: L34957 GeneJuice Transfection Reagent Sigma Cat: 70967 Polybrene Sigma Cat: TR-1003 Hygromycin Thermo Fisher Cat: 10687010 Puromycin Sigma Cat: P4512 Rv138891-105 peptide Genscript N/A Critical commercial assays Chromium Next GEM Single Cell V(D)J Reagent kits v1.1 10x Genomics N/A Chromium Next GEM Single Cell 5′ Reagent Kits v2 10x Genomics N/A Chromium Next GEM Single Cell 5′ HT Reagent Kit (v2) 10x Genomics N/A AllPrep DNA/RNA/miRNA Universal Kit Qiagen Cat: 80224 RNeasy MinElute Cleanup Kit Qiagen Cat: 74204 SMART-Seq Human TCR (with UMIs) kit Takara Bio Cat: 634779 QubitTM dsDNA Quantification Assay Kits Thermo Fisher Cat: Q32851 Qiagen RNeasy Micro kit Qiagen Cat: 74004 Deposited data scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Group 1 and Group 2) Gene Expression Omnibus GEO: GSE282132 scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Groups 3–5) Gene Expression Omnibus GEO: GSE301133 scTCR-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq/scTCR-seq data of PBMC samples from BCG-challenged volunteers in TB043 (Group 3) Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of PBMC samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of AIM+ T cells from BCG-challenged volunteers in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq of M.tb-infected non-human primates from Esaulova et al.31 Gene Expression Omnibus GEO: GSE149758 Bulk RNA-seq of cytokine stimulated human macrophages from Nilsson et al.30 Gene Expression Omnibus GEO: GSE20251 (Continued on next page) Cell Reports Medicine 7, 102830, June 16, 2026 e2 Article ll OPEN ACCESS

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Virus:

    Article Title: Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies TotalSeqTM-C0251 anti-human Hashtag 1 Antibody Biolegend Cat: 394661; RRID: AB_2801031 TotalSeqTM-C0252 anti-human Hashtag 2 Antibody Biolegend Cat: 394663; RRID: AB_2801032 TotalSeqTM-C0253 anti-human Hashtag 3 Antibody Biolegend Cat: 394665; RRID: AB_2801033 CD40 Antibody, anti-human Miltenyi Biotec Cat: 130-094-133; RRID: AB_2811582 BD HorizonTM BUV496 Mouse Anti-Human CD3 BD Biosciences Cat: 612940; RRID: AB_2870222 APC/Cyanine7 anti-human CD4 Antibody Biolegend Cat: 317418; RRID: AB_571947 FITC anti-human CD8a Antibody Biolegend Cat: 300906; RRID: AB_314110 Brilliant Violet 650TM anti-human CD14 Antibody Biolegend Cat: 301836; RRID: AB_2563799 Brilliant Violet 510TM anti-human CD19 Antibody Biolegend Cat: 302242; RRID: AB_2561668 Alexa Fluor® 700 anti-human CD56 (NCAM) Recombinant Antibody Biolegend Cat: 392418; RRID: AB_2728414 Brilliant Violet 605TM anti-human CD69 Antibody Biolegend Cat: 310938; RRID: AB_2562307 Alexa Fluor® 647 anti-human CD134 (OX40) Antibody Biolegend Cat: 350018; RRID: AB_2571938 PE/Cyanine5 anti-human CD137 (4-1BB) Antibody Biolegend Cat: 309808; RRID: AB_830670 PE/DazzleTM 594 anti-human CD154 (CD40L) Antibody Biolegend Cat: 310840; RRID: AB_2566245 APC anti-human CD80 Antibody Biolegend Cat: 375403; RRID: AB_2890817 PE anti-human HLA-DM Antibody Biolegend Cat: 358003; RRID: AB_2562027 Bacterial and virus strains BCG AJ Vaccines N/A Biological samples Fetal calf serum Labtech Cat: FCS-SA/500 Chemicals, peptides, and recombinant proteins RPMI 1640 Sigma Cat: R0883 L-glutamine Gibco Cat: G7513 Penicillin-streptomycin Gibco Cat: P0781 DMEM Sigma Cat: D6546 RPMI 1640 medium with 10 mM HEPES Gibco Cat: 22400089 GM-CSF PeproTech Cat: 300-03 IL-4 PeproTech Cat: 200-04 PPD-T AJ Vaccines NA RBC lysis solution Qiagen Cat: 158904 Sodium pyruvate Gibco Cat: 11360039 DMSO Sigma Cat: D2650 Lymphoprep Stemcell Technologies Cat: 7811 CD3 microbead Miltenyi Biotec Cat: 130-097-043 (Continued on next page) e1 Cell Reports Medicine 7, 102830, June 16, 2026 Article ll OPEN ACCESS .. REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcal Enterotoxin B Sigma Cat: S4881 Solution 13 Chemometec Cat: 910-3013 Human TruStain FcXTM BioLegend Cat: 422301 Dulbecco’s Phosphate Buffered Saline Sigma Cat: D8537 MACS® BSA Stock Solution Miltenyi Biotec Cat: 130-091-376 RLT Plus buffer Qiagen Cat: 1053393 β-mercaptoethanol Sigma Cat: M3148 RNase-free water Thermo Fisher Cat: AM9937 Benzonase Sigma Cat: E1014 LIVE/DEADTM Fixable Aqua Dead Cell Stain Kit Thermo Fisher Cat: L34957 GeneJuice Transfection Reagent Sigma Cat: 70967 Polybrene Sigma Cat: TR-1003 Hygromycin Thermo Fisher Cat: 10687010 Puromycin Sigma Cat: P4512 Rv138891-105 peptide Genscript N/A Critical commercial assays Chromium Next GEM Single Cell V(D)J Reagent kits v1.1 10x Genomics N/A Chromium Next GEM Single Cell 5′ Reagent Kits v2 10x Genomics N/A Chromium Next GEM Single Cell 5′ HT Reagent Kit (v2) 10x Genomics N/A AllPrep DNA/RNA/miRNA Universal Kit Qiagen Cat: 80224 RNeasy MinElute Cleanup Kit Qiagen Cat: 74204 SMART-Seq Human TCR (with UMIs) kit Takara Bio Cat: 634779 QubitTM dsDNA Quantification Assay Kits Thermo Fisher Cat: Q32851 Qiagen RNeasy Micro kit Qiagen Cat: 74004 Deposited data scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Group 1 and Group 2) Gene Expression Omnibus GEO: GSE282132 scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Groups 3–5) Gene Expression Omnibus GEO: GSE301133 scTCR-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq/scTCR-seq data of PBMC samples from BCG-challenged volunteers in TB043 (Group 3) Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of PBMC samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of AIM+ T cells from BCG-challenged volunteers in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq of M.tb-infected non-human primates from Esaulova et al.31 Gene Expression Omnibus GEO: GSE149758 Bulk RNA-seq of cytokine stimulated human macrophages from Nilsson et al.30 Gene Expression Omnibus GEO: GSE20251 (Continued on next page) Cell Reports Medicine 7, 102830, June 16, 2026 e2 Article ll OPEN ACCESS

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Red Blood Cell Lysis:

    Article Title: Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies TotalSeqTM-C0251 anti-human Hashtag 1 Antibody Biolegend Cat: 394661; RRID: AB_2801031 TotalSeqTM-C0252 anti-human Hashtag 2 Antibody Biolegend Cat: 394663; RRID: AB_2801032 TotalSeqTM-C0253 anti-human Hashtag 3 Antibody Biolegend Cat: 394665; RRID: AB_2801033 CD40 Antibody, anti-human Miltenyi Biotec Cat: 130-094-133; RRID: AB_2811582 BD HorizonTM BUV496 Mouse Anti-Human CD3 BD Biosciences Cat: 612940; RRID: AB_2870222 APC/Cyanine7 anti-human CD4 Antibody Biolegend Cat: 317418; RRID: AB_571947 FITC anti-human CD8a Antibody Biolegend Cat: 300906; RRID: AB_314110 Brilliant Violet 650TM anti-human CD14 Antibody Biolegend Cat: 301836; RRID: AB_2563799 Brilliant Violet 510TM anti-human CD19 Antibody Biolegend Cat: 302242; RRID: AB_2561668 Alexa Fluor® 700 anti-human CD56 (NCAM) Recombinant Antibody Biolegend Cat: 392418; RRID: AB_2728414 Brilliant Violet 605TM anti-human CD69 Antibody Biolegend Cat: 310938; RRID: AB_2562307 Alexa Fluor® 647 anti-human CD134 (OX40) Antibody Biolegend Cat: 350018; RRID: AB_2571938 PE/Cyanine5 anti-human CD137 (4-1BB) Antibody Biolegend Cat: 309808; RRID: AB_830670 PE/DazzleTM 594 anti-human CD154 (CD40L) Antibody Biolegend Cat: 310840; RRID: AB_2566245 APC anti-human CD80 Antibody Biolegend Cat: 375403; RRID: AB_2890817 PE anti-human HLA-DM Antibody Biolegend Cat: 358003; RRID: AB_2562027 Bacterial and virus strains BCG AJ Vaccines N/A Biological samples Fetal calf serum Labtech Cat: FCS-SA/500 Chemicals, peptides, and recombinant proteins RPMI 1640 Sigma Cat: R0883 L-glutamine Gibco Cat: G7513 Penicillin-streptomycin Gibco Cat: P0781 DMEM Sigma Cat: D6546 RPMI 1640 medium with 10 mM HEPES Gibco Cat: 22400089 GM-CSF PeproTech Cat: 300-03 IL-4 PeproTech Cat: 200-04 PPD-T AJ Vaccines NA RBC lysis solution Qiagen Cat: 158904 Sodium pyruvate Gibco Cat: 11360039 DMSO Sigma Cat: D2650 Lymphoprep Stemcell Technologies Cat: 7811 CD3 microbead Miltenyi Biotec Cat: 130-097-043 (Continued on next page) e1 Cell Reports Medicine 7, 102830, June 16, 2026 Article ll OPEN ACCESS .. REAGENT or RESOURCE SOURCE IDENTIFIER Staphylococcal Enterotoxin B Sigma Cat: S4881 Solution 13 Chemometec Cat: 910-3013 Human TruStain FcXTM BioLegend Cat: 422301 Dulbecco’s Phosphate Buffered Saline Sigma Cat: D8537 MACS® BSA Stock Solution Miltenyi Biotec Cat: 130-091-376 RLT Plus buffer Qiagen Cat: 1053393 β-mercaptoethanol Sigma Cat: M3148 RNase-free water Thermo Fisher Cat: AM9937 Benzonase Sigma Cat: E1014 LIVE/DEADTM Fixable Aqua Dead Cell Stain Kit Thermo Fisher Cat: L34957 GeneJuice Transfection Reagent Sigma Cat: 70967 Polybrene Sigma Cat: TR-1003 Hygromycin Thermo Fisher Cat: 10687010 Puromycin Sigma Cat: P4512 Rv138891-105 peptide Genscript N/A Critical commercial assays Chromium Next GEM Single Cell V(D)J Reagent kits v1.1 10x Genomics N/A Chromium Next GEM Single Cell 5′ Reagent Kits v2 10x Genomics N/A Chromium Next GEM Single Cell 5′ HT Reagent Kit (v2) 10x Genomics N/A AllPrep DNA/RNA/miRNA Universal Kit Qiagen Cat: 80224 RNeasy MinElute Cleanup Kit Qiagen Cat: 74204 SMART-Seq Human TCR (with UMIs) kit Takara Bio Cat: 634779 QubitTM dsDNA Quantification Assay Kits Thermo Fisher Cat: Q32851 Qiagen RNeasy Micro kit Qiagen Cat: 74004 Deposited data scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Group 1 and Group 2) Gene Expression Omnibus GEO: GSE282132 scRNA-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 (Groups 3–5) Gene Expression Omnibus GEO: GSE301133 scTCR-seq data of BAL samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq/scTCR-seq data of PBMC samples from BCG-challenged volunteers in TB043 (Group 3) Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of PBMC samples from BCG-challenged volunteers and saline controls in TB043 Gene Expression Omnibus GEO: GSE301133 Bulk TCR-seq data of AIM+ T cells from BCG-challenged volunteers in TB043 Gene Expression Omnibus GEO: GSE301133 scRNA-seq of M.tb-infected non-human primates from Esaulova et al.31 Gene Expression Omnibus GEO: GSE149758 Bulk RNA-seq of cytokine stimulated human macrophages from Nilsson et al.30 Gene Expression Omnibus GEO: GSE20251 (Continued on next page) Cell Reports Medicine 7, 102830, June 16, 2026 e2 Article ll OPEN ACCESS

    Immunopeptidomics:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Blocking Assay:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Cell Isolation:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Staining:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..

    Software:

    Article Title: Respiratory syncytial virus inhibits type I interferon signaling to maintain HLA-DM expression in CD1c+ dendritic cells
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER CD57 antibody (clone NK-1), BUV615 BD Biosciences RRID: AB_3752224 FOXP3 antibody (clone 259D/C7), PE BD Biosciences Cat#560046; RRID: AB_1645508 Ki67 antibody (clone Ki67, Alexa Fluor 488) BioLegend Cat#350508; RRID: AB_10933085 CTLA4 antibody (clone BNI3), PECy5 BD Biosciences Cat#555854; RRID: AB_396177 MHC I (HLA-A, B, C) blocking antibody (clone W6/32) BioLegend Cat#311412; RRID: AB_493132 Bacterial and virus strains Respiratory Syncytial Virus (RSV) ATCC Cat#VR-1540P Influenza A/PR/8/34 Charles River Cat#10100374 Biological samples Human PBMCs from healthy donors This study IRB Ref#2019-095 Chemicals, peptides, and recombinant proteins Poly I:C Miltenyi Biotec Cat#130-112-563 Lipopolysaccharide (LPS) Invitrogen/Life Technologies Cat#00-4976-93 Hoechst trihydrochloride trihydrate Thermo Fisher Scientific Cat#33342 BX795 Axon Medchem Cat#1390 MRT67307 MedChemExpress Cat#HY-13018 Tofacitinib citrate Tocris Cat#4556 R848 InvivoGen Cat#tlrl-r848-5 GM-CSF Miltenyi Biotec Cat#130-093-868 IL-4 Miltenyi Biotec Cat#130-093-924 Flt3-L Miltenyi Biotec Cat#130-096-480 IL-1β Miltenyi Biotec Cat#130-093-898 IL-2 Miltenyi Biotec Cat#130-097-744 IL-7 Miltenyi Biotec Cat#130-095-362 IL-15 Miltenyi Biotec Cat#130-095-766 Influenza A/04/09/California peptide mix JPT Technologies Cat#PM-INFA-HACal Full-length HA peptide Sino Biological Cat#11085-V08B-100 Critical commercial assays CD3 MicroBeads Miltenyi Biotec Cat#130-097-043 CD19 MicroBeads Miltenyi Biotec Cat130-119-475 CD14 MicroBeads Miltenyi Biotec Cat#130-050-201 CD56 MicroBeads Miltenyi Biotec Cat#130-097-042 Granulocyte Isolation Beads Miltenyi Biotec Cat#130-126-448 Human Blood Dendritic Cell Isolation Kit Invitrogen Cat#11308D Near IR live/dead viability stain Invitrogen Cat#L34976 FOXP3/Transcription Factor Staining Buffer Set Invitrogen Cat#00-5523-00 BD Phosfix Buffer 1 BD Biosciences Cat#557870 BD Phosflow Perm/Wash Buffer 1 BD Biosciences Cat#557885 Milliplex 9-plex Human Interferon Panel Merck Millipore Cat#HIFN-130K-09 Deposited data scRNA-seq raw data and code This paper GEO: GSE334417; Zenodo: https://doi.org/10.5281/ zenodo.20546842; https://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE334417 Software and algorithms FlowJo v6.0 BD Biosciences https://www.flowjo.com/ GraphPad Prism v9.5.1 GraphPad https://www.graphpad.com/ R v4.2.2 R Foundation https://www.r-project.org/ Seurat v4.3.0 Satija Lab https://satijalab.org/seurat/ ZEN Blue ZEISS https://www.zeiss.com/ iScience 29, 116736, August 21, 2026 e2 ..



    Similar Products

    96
    Miltenyi Biotec cd3 magnetic beads
    Cd3 Magnetic Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human/pmc13431687-211-9-12
    Average 96 stars, based on 1 article reviews
    cd3 magnetic beads - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd19 microbeads miltenyi biotec
    Cd19 Microbeads Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human+-+lyophilized/10__1016_slash_j__isci__2026__116736-639-169-171
    Average 96 stars, based on 1 article reviews
    cd19 microbeads miltenyi biotec - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd3 t cell isolation kit 896
    Cd3 T Cell Isolation Kit 896, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human/pm42374531-323-24-29
    Average 96 stars, based on 1 article reviews
    cd3 t cell isolation kit 896 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec cd3 microbeads
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Cd3 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3%CE%B5+Antibody%2C+anti-mouse%2C+REAfinity/pmc13139981-219-23-25
    Average 99 stars, based on 1 article reviews
    cd3 microbeads - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec immunomagnetic sorting
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Immunomagnetic Sorting, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human+-+lyophilized/pmc13271331-39-6-8
    Average 96 stars, based on 1 article reviews
    immunomagnetic sorting - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec anti cd3 microbeads
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Anti Cd3 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human/pmc13291024-55-4-8
    Average 96 stars, based on 1 article reviews
    anti cd3 microbeads - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec human cd3 microbeads
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Human Cd3 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/Pan+T+Cell+Isolation+Kit+II%2C+mouse/pmc13265216-130-14-17
    Average 97 stars, based on 1 article reviews
    human cd3 microbeads - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd3 microbead miltenyi biotec cat
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Cd3 Microbead Miltenyi Biotec Cat, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3+MicroBeads%2C+human+-+lyophilized/pm42167232-239-252-254
    Average 96 stars, based on 1 article reviews
    cd3 microbead miltenyi biotec cat - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec anti human cd3 microbeads
    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, <t>CD3</t> + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.
    Anti Human Cd3 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+microbeads/CD3%CE%B5+Antibody%2C+anti-mouse%2C+REAfinity/pm42144489-51-15-18
    Average 99 stars, based on 1 article reviews
    anti human cd3 microbeads - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, CD3 + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

    doi: 10.1016/j.omtn.2026.102929

    Figure Lengend Snippet: Transfection efficacy of CD19-CAR mRNA and co-expression of multiple IVT mRNAs in polyclonally activated T cells (A) Experimental workflow: PBMCs from healthy donors were isolated, CD3 + T cells enriched by MACS, polyclonally activated with plate-bound anti-CD3/CD28 antibodies for 48 h, and electroporated with IVT mRNA on day 3. Created with BioRender.com . (B and C) Flow cytometric analysis of CD19-CAR + frequency (B) and CD19-CAR molecules per cell (C) in CD3 + , CD4 + , and CD8 + T cell subsets at 8 h and 24 h post-electroporation. (D) Schematic of single and co-transfection approach using CD19-CAR ± CCR7 mRNA. Created with BioRender.com . (E) Representative plots of mock-transfected control, CD19-CAR-only, CCR7-only, and CD19-CAR + CCR7 co-transfected T cells, showing CD19-CAR and CCR7 expression 8 h post-transfection. (F) Viability of T cells following single and dual mRNA transfection, assessed by live/dead staining 8 h post-transfection. (G–I) Quantification of CD19-CAR-only versus CD19-CAR + CCR7 co-expression: CD19-CAR + frequency (G), CD19-CAR geometric mean fluorescence intensity (H), and CCR7 geometric mean fluorescence intensity (I) in CD3 + T cells, 8 h after mRNA transfection ( n = 8 donors). (J) Schematic of multiplexing approach using four IVT mRNAs (CD19-CAR, CCR7, CXCR3, and GFP). Created with BioRender.com . (K–N) Flow cytometric analysis of four-mRNA multiplexing showing frequency of CD19-CAR + GFP + double-positive cells (K and L) and geometric mean fluorescence intensity of CXCR3 (M) and CCR7 (N), 8 h post-transfection ( n = 3 donors). Statistical analysis between subpopulations was performed by one-way ANOVA with Tukey’s post hoc test or paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from the indicated number of independent donors.

    Article Snippet: PBMCs were isolated from healthy donors using Biocoll (Biochrom) gradient centrifugation, and CD3 + T cells were enriched using magnetic cell separation with CD3 Microbeads (Miltenyi Biotec).

    Techniques: Transfection, Expressing, Isolation, Electroporation, Cotransfection, Control, Staining, Fluorescence, Multiplexing

    Memory phenotype characterization of IVT mRNA-transfected CD19-CAR T cells (A) Representative flow cytometry plots showing the gating strategy for CD8 + memory T cell subsets in primary human CD3 + -enriched T cells. Subsets were defined by CD3 + , CD4 – , CD8 + , and CCR7/CD45RA expression as follows: naive like (T naive like ; CCR7 + CD45RA + ), central memory (T CM ; CCR7 + CD45RA – ), effector memory (T EM ; CCR7 – CD45RA – ), and terminally differentiated effector (T EMRA ; CCR7 – CD45RA + ). (B) Frequencies of CD4 + and CD8 + T cells within CD19-CAR + populations compared with mock-transfected controls after electroporation or LNP transfection. (C and D) Geometric mean fluorescence intensity (gMFI) of CD19-CAR expression in bulk CD4 + (C) and CD8 + (D) T cell populations following electroporation or LNP-mediated transfection; representative experiment. (E and F) CD19-CAR surface expression across memory T cell subsets within the CD8 + population following electroporation (E) or LNP-mediated (F) mRNA delivery over 108 h post-transfection. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test (B) or by two-way repeated-measures ANOVA with Šidák’s multiple-comparison test (E and F). ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from n = 4 independent donors, unless stated otherwise.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

    doi: 10.1016/j.omtn.2026.102929

    Figure Lengend Snippet: Memory phenotype characterization of IVT mRNA-transfected CD19-CAR T cells (A) Representative flow cytometry plots showing the gating strategy for CD8 + memory T cell subsets in primary human CD3 + -enriched T cells. Subsets were defined by CD3 + , CD4 – , CD8 + , and CCR7/CD45RA expression as follows: naive like (T naive like ; CCR7 + CD45RA + ), central memory (T CM ; CCR7 + CD45RA – ), effector memory (T EM ; CCR7 – CD45RA – ), and terminally differentiated effector (T EMRA ; CCR7 – CD45RA + ). (B) Frequencies of CD4 + and CD8 + T cells within CD19-CAR + populations compared with mock-transfected controls after electroporation or LNP transfection. (C and D) Geometric mean fluorescence intensity (gMFI) of CD19-CAR expression in bulk CD4 + (C) and CD8 + (D) T cell populations following electroporation or LNP-mediated transfection; representative experiment. (E and F) CD19-CAR surface expression across memory T cell subsets within the CD8 + population following electroporation (E) or LNP-mediated (F) mRNA delivery over 108 h post-transfection. Statistical analysis was performed by one-way ANOVA with Tukey’s post hoc test (B) or by two-way repeated-measures ANOVA with Šidák’s multiple-comparison test (E and F). ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from n = 4 independent donors, unless stated otherwise.

    Article Snippet: PBMCs were isolated from healthy donors using Biocoll (Biochrom) gradient centrifugation, and CD3 + T cells were enriched using magnetic cell separation with CD3 Microbeads (Miltenyi Biotec).

    Techniques: Transfection, Flow Cytometry, Expressing, Electroporation, Fluorescence, Comparison

    Functional characterization of CD19-CAR mRNA transfected T cells following antigen encounter (A) Experimental workflow of the overnight stimulation assay: mock-transfected and mRNA-transfected CD19-CAR T cells were stimulated with NALM6 (CD19 + ) cells for 16 h in the presence of brefeldin A to capture intracellular cytokine production by flow cytometry. Created with BioRender.com . (B) Representative flow cytometry plots showing activation marker expression (CD137 and CD154) in CD3 + T cells with (stimulated) and without (unstimulated) target cell stimulation. Comparisons are shown for electroporated (left) and LNP-transfected (right) CD19-CAR T cells. (C) Frequencies of activated (CD137 + and/or CD154 + ) CD3 + , CD4 + , and CD8 + T cell populations, comparing electroporation and LNP delivery methods. Data are background-subtracted. (D) Intracellular effector cytokine production (IFN-γ and TNF-α) within activated CD3 + , CD4 + , and CD8 + T cell populations. Data showing the relative increase in cytokine-producing T cells for LNP transfection normalized to electroporation. Statistical analysis was performed by paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from n = 4 independent donors.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

    doi: 10.1016/j.omtn.2026.102929

    Figure Lengend Snippet: Functional characterization of CD19-CAR mRNA transfected T cells following antigen encounter (A) Experimental workflow of the overnight stimulation assay: mock-transfected and mRNA-transfected CD19-CAR T cells were stimulated with NALM6 (CD19 + ) cells for 16 h in the presence of brefeldin A to capture intracellular cytokine production by flow cytometry. Created with BioRender.com . (B) Representative flow cytometry plots showing activation marker expression (CD137 and CD154) in CD3 + T cells with (stimulated) and without (unstimulated) target cell stimulation. Comparisons are shown for electroporated (left) and LNP-transfected (right) CD19-CAR T cells. (C) Frequencies of activated (CD137 + and/or CD154 + ) CD3 + , CD4 + , and CD8 + T cell populations, comparing electroporation and LNP delivery methods. Data are background-subtracted. (D) Intracellular effector cytokine production (IFN-γ and TNF-α) within activated CD3 + , CD4 + , and CD8 + T cell populations. Data showing the relative increase in cytokine-producing T cells for LNP transfection normalized to electroporation. Statistical analysis was performed by paired t test. ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SD from n = 4 independent donors.

    Article Snippet: PBMCs were isolated from healthy donors using Biocoll (Biochrom) gradient centrifugation, and CD3 + T cells were enriched using magnetic cell separation with CD3 Microbeads (Miltenyi Biotec).

    Techniques: Functional Assay, Transfection, Flow Cytometry, Activation Assay, Marker, Expressing, Cell Stimulation, Electroporation

    Functional characterization of CD19-CAR T cells produced by LNP-mediated versus electroporation-based mRNA delivery (A) Experimental workflow: electroporated and LNP-transfected T cells were assessed in an in vitro transwell assay, first migrating toward CCL21 for 3 h, followed by co-culture with NALM6 target cells (CD19 + GFP + ). Killing efficiency was monitored over 28 h with 4-h intervals using live-cell imaging. Created with BioRender.com . (B) Killing efficacy of NALM6 (CD19 + GFP + ) target cells using untouched, mock-transfected and CD19-CAR mRNA transfected T cells (EP and LNP) over 28 h assessed using live-cell imaging every 4 h. (C) Area under the curve (AUC) analysis of total killing capacity over the 28-h observation period for the same groups relative to untouched T cells. (D) Fold increase of migrated CD3 + T cells toward CCL21 chemokine normalized to untouched T cells comparing LNP and electroporation delivery methods for mock-transfected and CD19-CAR mRNA transfected T cells analyzed using flow cytometry. (E) Flow cytometric analysis of exhaustion marker expression (TIM-3 and LAG-3) in CD3 + , CD4 + and CD8 + T cell populations following cytotoxic activity of LNP-transfected T cells normalized to electroporated T cells. (F) Mean percentage of CAR T cells expressing zero, one, two, or three exhaustion markers in electroporated T cells (upper) and LNP-transfected CD19-CAR T cells (lower) following cytotoxic activity. (G) Supernatants from migrated T cell killing assays were collected and analyzed for pro-inflammatory cytokines. Mean levels of granzyme B, IFN-γ, TNF-α, IL-8, and IL-10 are shown. Normalized to CD19-CAR frequency for each sample. Statistical analysis for differences between subpopulations was performed by Friedman test followed by Dunn’s multiple comparison test (C, D, and G) or paired t test (E). ∗ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SEM from n = 4 independent donors.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

    doi: 10.1016/j.omtn.2026.102929

    Figure Lengend Snippet: Functional characterization of CD19-CAR T cells produced by LNP-mediated versus electroporation-based mRNA delivery (A) Experimental workflow: electroporated and LNP-transfected T cells were assessed in an in vitro transwell assay, first migrating toward CCL21 for 3 h, followed by co-culture with NALM6 target cells (CD19 + GFP + ). Killing efficiency was monitored over 28 h with 4-h intervals using live-cell imaging. Created with BioRender.com . (B) Killing efficacy of NALM6 (CD19 + GFP + ) target cells using untouched, mock-transfected and CD19-CAR mRNA transfected T cells (EP and LNP) over 28 h assessed using live-cell imaging every 4 h. (C) Area under the curve (AUC) analysis of total killing capacity over the 28-h observation period for the same groups relative to untouched T cells. (D) Fold increase of migrated CD3 + T cells toward CCL21 chemokine normalized to untouched T cells comparing LNP and electroporation delivery methods for mock-transfected and CD19-CAR mRNA transfected T cells analyzed using flow cytometry. (E) Flow cytometric analysis of exhaustion marker expression (TIM-3 and LAG-3) in CD3 + , CD4 + and CD8 + T cell populations following cytotoxic activity of LNP-transfected T cells normalized to electroporated T cells. (F) Mean percentage of CAR T cells expressing zero, one, two, or three exhaustion markers in electroporated T cells (upper) and LNP-transfected CD19-CAR T cells (lower) following cytotoxic activity. (G) Supernatants from migrated T cell killing assays were collected and analyzed for pro-inflammatory cytokines. Mean levels of granzyme B, IFN-γ, TNF-α, IL-8, and IL-10 are shown. Normalized to CD19-CAR frequency for each sample. Statistical analysis for differences between subpopulations was performed by Friedman test followed by Dunn’s multiple comparison test (C, D, and G) or paired t test (E). ∗ns, not significant; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. Data represent mean ± SEM from n = 4 independent donors.

    Article Snippet: PBMCs were isolated from healthy donors using Biocoll (Biochrom) gradient centrifugation, and CD3 + T cells were enriched using magnetic cell separation with CD3 Microbeads (Miltenyi Biotec).

    Techniques: Functional Assay, Produced, Electroporation, Transfection, In Vitro, Transwell Assay, Co-Culture Assay, Live Cell Imaging, Flow Cytometry, Marker, Expressing, Activity Assay, Comparison